Skip To Main Content
Levicatus Mugenyi on Muck Rack

Levicatus Mugenyi

As seen in: Nature, Thorax
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Levicatus

Contact Levicatus, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study | Molecular Psychiatry

|
By Levicatus Mugenyi, Marina Sánchez-Rico, Henry Bossa Kyobe, Hellen T Aanyu, Pauline Byakika-Kibwika, Ivan Segawa
| Nature Verified
Abstract Prior research suggests that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) used for the treatment of obsessive-compulsive disorder and major depressive disorder, could be repurposed against COVID-19. We undertook a prospective interventional open-label cohort study to evaluate the efficacy and tolerability of fluvoxamine among inpatients with laboratory-confirmed COVID-19 in Uganda. The main outcome was all-cause mortality.
Open in Who Shared Issue with article?

Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study

|
By Andrew I Kazibwe, Levicatus Mugenyi, Bonniface Oryokot, David Kagimu
| PLOS
Patient demographics A total of 3688 individuals were initiated on IPT during the study period but 1034 were excluded due to incomplete information (see Table 1 attached as supporting document). Therefore, we collected data on the remaining 2634 PLHIV. Of the 2634 PLHIV on ART who were initiated on IPT, majority were females (65.6%), had been on ART for more than 36 months (63.3%) and initiated IPT in 2017 (67.1%) (Table 1).
Open in Who Shared Issue with article?

Feasibility of using a mobile App to monitor and report COVID-19 related symptoms and people’s movements in Uganda

|
By Levicatus Mugenyi, Winters Muttamba, Rebecca Namugabwe Nsubuga, Irene Wanyana
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Levicatus Mugenyi , Rebecca Namugabwe Nsubuga, Irene Wanyana, Winters Muttamba, Nazarius Mbona Tumwesigye, Saul Hannington Nsubuga Levicatus Mugenyi, Rebecca Namugabwe Nsubuga, Irene Wanyana, Winters Muttamba, Nazarius Mbona Tumwesigye, Saul Hannington Nsubuga Published: November 19, 2021 https://doi.org/10.1371/journal.pone.0260269 Figures Abstract Background Feasibility of mobile Apps to monitor diseases has not been well documented...
Open in Who Shared Issue with article?
See all 5 licensed articles (6 Total)